Present and future role of endoscopic retrograde cholangiography in primary sclerosing cholangitis
Standard
Present and future role of endoscopic retrograde cholangiography in primary sclerosing cholangitis. / Waldthaler, A; Schramm, C; Bergquist, A.
in: EUR J MED GENET, Jahrgang 64, Nr. 6, 06.2021, S. 104231.Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › SCORING: Review › Forschung
Harvard
APA
Vancouver
Bibtex
}
RIS
TY - JOUR
T1 - Present and future role of endoscopic retrograde cholangiography in primary sclerosing cholangitis
AU - Waldthaler, A
AU - Schramm, C
AU - Bergquist, A
N1 - Copyright © 2021. Published by Elsevier Masson SAS.
PY - 2021/6
Y1 - 2021/6
N2 - Primary sclerosing cholangitis (PSC) is a rare, inflammatory cholestatic liver disease that causes biliary strictures which can lead to secondary complications. About 30-50% of PSC patients develop dominant strictures (DS) in the biliary tree, which are both the cause of jaundice and bacterial cholangitis as well as predilection spots for development of neoplastic development. Cancer is the most common cause of death in PSC. A central concern is to distinguish malignant from benign strictures, which eventually is done by invasive methods to obtain a brush cytology or biopsy sample, in most cases via endoscopic retrograde cholangiography-pancreatography (ERCP). Since medical therapies, like ursodesoxycholic acid or immunosuppressive drugs have no proven effect, therapeutic ERCP has become the primary management strategy to improve symptoms and in some patients may slow down disease progression. This article aims at outlining the current and emerging methods in ERCP in PSC patients.
AB - Primary sclerosing cholangitis (PSC) is a rare, inflammatory cholestatic liver disease that causes biliary strictures which can lead to secondary complications. About 30-50% of PSC patients develop dominant strictures (DS) in the biliary tree, which are both the cause of jaundice and bacterial cholangitis as well as predilection spots for development of neoplastic development. Cancer is the most common cause of death in PSC. A central concern is to distinguish malignant from benign strictures, which eventually is done by invasive methods to obtain a brush cytology or biopsy sample, in most cases via endoscopic retrograde cholangiography-pancreatography (ERCP). Since medical therapies, like ursodesoxycholic acid or immunosuppressive drugs have no proven effect, therapeutic ERCP has become the primary management strategy to improve symptoms and in some patients may slow down disease progression. This article aims at outlining the current and emerging methods in ERCP in PSC patients.
U2 - 10.1016/j.ejmg.2021.104231
DO - 10.1016/j.ejmg.2021.104231
M3 - SCORING: Review article
C2 - 33905896
VL - 64
SP - 104231
JO - EUR J MED GENET
JF - EUR J MED GENET
SN - 1769-7212
IS - 6
ER -